tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi (FR:SAN)
:SAN
France Market
SAN
Sanofi
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Sanofi (SAN) Stock News & Sentiment

Compare
183 Followers
Sanofi’s Strategic Acquisition of Blueprint Medicines: A Boost to Rare Disease Portfolio and Long-term Growth
Premium
Ratings
Sanofi’s Strategic Acquisition of Blueprint Medicines: A Boost to Rare Disease Portfolio and Long-term Growth
5d ago
SNY
Sanofi’s Promising Pipeline and Competitive Positioning Justify Buy Rating Despite Mixed Study Results
Premium
Ratings
Sanofi’s Promising Pipeline and Competitive Positioning Justify Buy Rating Despite Mixed Study Results
11d ago
SNY
Sanofi’s Promising Pipeline and Undervaluation Support Buy Rating
Premium
Ratings
Sanofi’s Promising Pipeline and Undervaluation Support Buy Rating
25d ago
SNY
Sanofi’s Undervalued Stock and Promising Growth Justify Buy Rating
Premium
Ratings
Sanofi’s Undervalued Stock and Promising Growth Justify Buy Rating
1M ago
SNY
Sanofi Reports Strong Q1 2025 Performance
Premium
Company Announcements
Sanofi Reports Strong Q1 2025 Performance
2M ago
Sanofi’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Sanofi’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
2M ago
SNY
Sanofi’s Strong Financial Performance and Promising R&D Pipeline Justify Buy Rating
Premium
Ratings
Sanofi’s Strong Financial Performance and Promising R&D Pipeline Justify Buy Rating
2M ago
SNY
More FR:SAN News >

SAN News on the Web

Sanofi Speeds Up Global Beyfortus Shipments Ahead Of 2025-2026 RSV Season
rttnews
Neutral
Sanofi's Rilzabrutinib Granted FDA's Orphan Drug Designation To Treat Sickle Cell Disease
rttnews
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Nurix Therapeutics (NRIX), Sanofi (SNYNF)
TipRanks News
Neutral
Stocks making the biggest premarket moves: Cleveland-Cliffs, Nucor, Moderna, Tesla and more
CNBC
Neutral
Sanofi acquisition of Blueprint Medicines 'sensible,' says BofA
The Fly
Neutral
Berenberg Bank Sticks to Their Buy Rating for Sanofi (SNY)
TipRanks News
Neutral
Berenberg Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)
TipRanks News
Neutral
Sanofi To Acquire Blueprint Medicines In $9.5 Bln Deal
rttnews
Neutral

News Score - Last 7 Days

Neutral
FR:SAN
Sector Average
Media Buzz
This Week2 articles
Weekly Average6.5 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:SAN’s Media Buzz Sentiment?
2 articles about FR:SAN were published this week. In an average week, 6.5 articles are published.
    What is FR:SAN’s weekly average amount of articles?
    In an average week, 6.5 articles about FR:SAN are published.
      What is FR:SAN’s News Sentiment?
      50% of articles about FR:SAN were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        CPRXCatalyst Pharma
        HQYHealthequity
        HIMSHims & Hers Health
        THCTenet Healthcare
        RDYDr Reddy's Laboratories
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing